Clinical Trials in New York

Showing 20201-20220 of 22,668 trials

Gemcitabine Hydrochloride and Alvocidib in Treating Patients With Solid Tumors

NCT00072436

This phase I trial is studying the side effects and best dose of gemcitabine hydrochloride and alvocidib in treating patients with solid tumors. Drugs used in chemotherapy, such as gemcitabine hydrochloride and alvocidib, use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells

Unspecified Adult Solid Tumor, Protocol Specific

National Cancer Institute (NCI)58 participantsStarted Sep 2003

Boston, Massachusetts, United States • Boston, Massachusetts, United States • New York, New York, United States

COMPLETEDPhase 2< 1 mile

Clinical Trial To Evaluate ANT-1207 In Subjects With Crow's Feet

NCT01358695

The purpose of this study is to provide evidence of the safety, tolerance, and efficacy of ANT-1207 in the treatment of Crow's Feet.

Lateral Canthal LinesCrow's Feet

Anterios Inc.111 participantsStarted May 2011

Birmingham, Alabama, United States • Miami Beach, Florida, United States • West Palm Beach, Florida, United States +3 more locations

WITHDRAWNNA< 1 mile

Clinical Evaluation of the CADenceTM System in Detection of Coronary Artery Diseases

NCT01584622

The purpose of the study is to evaluate the effectiveness of the CADence system, a non-invasive device, in detecting greater than or equal to 50% coronary stenosis anywhere in the coronary tree.

Coronary Artery Disease

AUM Cardiovascular, Inc.Started Jul 2012

Des Moines, Iowa, United States • Coon Rapids, Minnesota, United States • Minneapolis, Minnesota, United States +4 more locations

Gemcitabine Hydrochloride and Alvocidib in Treating Patients With Solid Tumors

Clinical Trial To Evaluate ANT-1207 In Subjects With Crow's Feet

Clinical Evaluation of the CADenceTM System in Detection of Coronary Artery Diseases

Find Trials by Condition in New York

NYC Heart Follow-Up Study 2010

Interleukin-2 in Treating Children Who Have Undergone Bone Marrow Transplantation for Acute Myeloid Leukemia

Ifosfamide and Topotecan in Treating Patients With Refractory Solid Tumors

Combination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome

Registration and Informed Consent Study for the Childhood Cancer Research Network

Paclitaxel in Treating Patients With Recurrent or Progressive Advanced Ovarian Cancer

Nolatrexed Dihydrochloride Compared With Doxorubicin in Treating Patients With Recurrent or Unresectable Liver Cancer

Thalidomide and Cyclophosphamide in Treating Children With Recurrent or Refractory Childhood Cancers

Diet and PSA Levels in Patients With Prostate Cancer

Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery

Microsurgical Varicocelectomy Versus No Surgery in Men With a Palpable Varicocele and an Abnormal Semen Analysis

First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer

Biodistribution and Dosimetry Evaluation of [124I]FIAU

Injection Site Tolerability, Safety, Pharmacokinetics and Pharmacodynamics Study After a Single Dose Subcutaneous Treatment of Alirocumab SAR236553 (REGN727)

Study of the Tolerability, Safety, Pharmacokinetics and Pharmacodynamics of Alirocumab SAR236553 (REGN727)

Injection Site Tolerability, Safety, Pharmacokinetics, Pharmacodynamics in Different Single-Dose Treatments of Alirocumab SAR236553 (REGN727) in Healthy Subjects

A Study to Assess AFM13 in Patients With Hodgkin Lymphoma